Showing results (21-30 of 197) with videos related to
Sort By:
Pageof 20
European Respiratory Review : an Official Journal of the European Respiratory Society|November 18, 2021
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysisEline Schillebeeckx, Jan P van Meerbeeck, Kevin LamoteCritical Reviews in Oncology/Hematology|August 11, 2020
Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic reviewEline Janssens, Jan P van Meerbeeck, Kevin LamoteJournal of Medical Biography|September 3, 2009
Tuberculosis in the Ottoman harem in the 19th centuryY Izzetin Baris, Gunnar HillerdalScandinavian Journal of Work, Environment & Health|January 24, 2006
Pleuropulmonary lesions, ergotamines and asbestos exposureGunnar Hillerdal, Anna Rask-AndersenJournal of Advanced Research|August 11, 2015
Mesothelioma treatment: Are we on target? A reviewBirgitta I Hiddinga, Christian Rolfo, Jan P van MeerbeeckCurrent Opinion in Oncology|February 25, 2010
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancerSofie De Craene, Veerle Surmont, Jan P van MeerbeeckExpert Review of Anticancer Therapy|February 19, 2008
What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Jan P Van Meerbeeck, Rebecca De Pauw, Kurt TournoyLung Cancer (Amsterdam, Netherlands)|June 16, 2010
Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancerGunnar Hillerdal, Christer Sederholm, Kerstin AnderssonExpert Review of Anticancer Therapy|June 17, 2014
Novel treatment options in stage I non-small-cell lung cancerSvitlana Tarasevych, Patrick Lauwers, Frederik Vandaele, et al.Lung Cancer (Amsterdam, Netherlands)|March 14, 2002
A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habitsHirsh Koyi, Gunnar Hillerdal, Eva BrandénPageof 20